Načítá se...
Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
AIMS/INTRODUCTION: Chemerin, a novel member of the family of adipocytokines, has been shown to be associated with insulin resistance, as well as micro‐ and macrovascular complications of diabetes. We investigated the effects of pioglitazone and metformin, two commonly prescribed antidiabetic agents,...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley-Blackwell
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4020338/ https://ncbi.nlm.nih.gov/pubmed/24843782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12157 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|